started · updated
RSV vaccination provides protection for at least three seasons, expert says
Professor Piotr Rzymski from Poznan University of Medical Sciences states that RSV vaccination protects against severe lower respiratory tract infections for at least three infectious seasons. Respiratory Syncytial Virus (RSV) is a common cause of respiratory infections, transmitted via droplets, and poses the highest risk to infants and young children.
However, the virus also threatens adults over 60 and individuals with comorbidities such as asthma, COPD, diabetes, obesity, or cardiovascular diseases. Severe RSV infections often require hospitalizations lasting more than a week. Research indicates that survivors face an increased risk of serious cardiovascular incidents, including heart attacks and strokes, particularly within the first month following infection, though this risk can persist for up to 12 months.
Furthermore, severe RSV infections can lead to secondary bacterial infections, such as those caused by Staphylococcus aureus or Haemophilus influenzae, due to the impairment of respiratory cilia which normally clear mucus and pathogens.